Israel Englander Vaccinex, Inc. Transaction History

Millennium Management LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.39 - $0.65 $28,522 - $47,537	73,134 Added 192.64%	111,098 $44,000
Q4 2022 Feb 14, 2023	SELL	$0.44 - $131.17 $14,452 - $4.31 Million	-32,847 Reduced 46.39%	37,964 $25,000
Q3 2022 Nov 14, 2022	SELL	$0.48 - $109.22 $38,810 - $8.83 Million	-80,855 Reduced 53.31%	70,811 $35,000
Q2 2022 Aug 15, 2022	BUY	$1.05 - $1.39 $126,826 - $167,893	120,787 Added 391.16%	151,666 $164,000
Q1 2022 May 16, 2022	BUY	$0.92 - $1.94 $28,408 - $59,905	30,879 New	30,879 $41,000
Q3 2020 Nov 16, 2020	SELL	$1.75 - $8.19 $53,886 - $252,186	-30,792 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$3.28 - $4.24 $44,942 - $58,096	-13,702 Reduced 30.8%	30,792 $111,000
Q1 2020 May 14, 2020	SELL	$3.96 - $8.37 $47,626 - $100,665	-12,027 Reduced 21.28%	44,494 $178,000
Q4 2019 Feb 14, 2020	SELL	$4.56 - $7.45 $40,793 - $66,647	-8,946 Reduced 13.66%	56,521 $274,000
Q3 2019 Nov 14, 2019	SELL	$4.02 - $7.93 $5,828 - $11,498	-1,450 Reduced 2.17%	65,467 $469,000
Q2 2019 Aug 14, 2019	SELL	$4.89 - $8.11 $17,648 - $29,268	-3,609 Reduced 5.12%	66,917 $369,000
Q1 2019 May 14, 2019	SELL	$3.67 - $5.5 $10,488 - $15,719	-2,858 Reduced 3.89%	70,526 $371,000
Q4 2018 Feb 14, 2019	SELL	$3.64 - $7.12 $37,779 - $73,898	-10,379 Reduced 12.39%	73,384 $276,000
Q3 2018 Nov 14, 2018	BUY	$6.95 - $11.64 $582,152 - $975,001	83,763 New	83,763 $580,000

426K

Ticker VCNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,664,100
Market Cap $46.5M
Description
Vaccinex, Inc., a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs. The company offers its products for the treatment of cancer, neurodegenerative diseases, and autoimmune disorders. Its lead product candidate is pepinemab,...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.